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Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children. Intra-articular corticosteroid
injection (IASI), one of the cornerstones of treatment for this disease, is usually associated with anxiety and pain. IASI in
JIA may be performed under general anesthesia, conscious sedation, or local anesthesia alone. Currently, there is no
widely accepted standard of care regarding the sedation method for IASI. This review discusses the different methods
of anesthesia and sedation in this procedure, emphasizing the advantages and shortcomings of each method.
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A 2 year old girl who has been diagnosed with oligoarti-
cular juvenile idiopathic arthritis (JIA) is due for intra-
articular corticosteroid injection (IASI) to her right knee.
What is the recommended sedation technique for her?
Introductory case 2
A 9 year old girl has a 4-year history of oligoarticular
JIA. She has been taking methotrexate for a year and
now has presented to the Rheumatology Clinic with
exacerbation of left ankle arthritis. She had an IASI to
the same joint a year ago. What would be the preferred
sedation technique for her?
Background
JIA is the most common rheumatic disease of childhood
[1]. Management of JIA includes a combination of
pharmacological interventions, physical and occupational
therapy, and psychosocial support [2]. Intra-articular
corticosteroid injections (IASI) are one of the mainstays of
treatment for children with JIA, particularly children with
oligoarticular JIA [3]. It may be the only therapy needed
for those patients, obviating the need for prolonged daily
treatment. Studies have shown that as many as 70 % of* Correspondence: uziely@zahav.net.il
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disease in the injected joint for at least 1 year and 40 % for
more than 2 years [4]. The most significant disadvantage
of IASI is the pain and anxiety associated with the proced-
ure. Various elements interact to influence the child’s pain
experience. Among them are environmental, cognitive,
behavioral and biological factors (Fig. 1).
Several studies in this field have shown that a child’s
level of anxiety before a painful medical procedure is
directly correlated with the amount of pain experienced
[5, 6]. Since children with JIA frequently require repeated
injections during their illness, extra care should be taken
in making the injection procedure as painless and as stress
free as possible, especially the first injection.
IASI in JIA may be performed under general
anesthesia, conscious sedation, or local anesthesia alone.
The choice of sedation or anesthesia should be tailored
to the patient’s needs. The sedation can be administered
by an anesthesiologist or by a non-anesthesiologist
physician (e.g. nurse practitioner) who has undergone a
specialized sedation course. Despite the frequent use of
IASI in the management of JIA, there have been only
few studies regarding the efficacy of different methods of
anesthesia and sedation for this procedure [7]. Thus,
there is currently no widely accepted standard of care in
this field. This review discusses each of these methods.article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in
operly credited. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Factors influencing the child’s pain experience. Biological, cognitive behavioral and environmental factors interact to influence a child’s
pain perception
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Local anesthesia used in IASI includes a variety of agents,
such as eutectic lidocaine/prilocaine cream (EMLA)
cream, subcutaneous lidocaine and ethyl chloride
spray.
EMLA, a mixture of topical lidocaine and prilocaine,
is a water emulsion cream applied to the skin under
occlusive dressing 60 minutes prior to the procedure. It
is widely used in young children for pain-related proce-
dures [8]. Uziel et al. assessed its role in IASI and found
it to have no statistically significant analgesic effect on
pain associated with joint injections, when used alone
[9]. The depth of EMLA analgesic effect has been shown
to be approximately 3 mm after 60 minutes of skin
application. The synovial membrane is usually deeper
than 5 mm, which may explain the ineffectiveness of
EMLA cream in achieving adequate analgesic effect for
IASI. However, application of the cream has a placebo
effect that has been reported in numerous studies [10].
The placebo effect by itself can alleviate some of the
pain associated with painful procedures, including IASI.
Subcutaneous injection of lidocaine 2 % solution is
commonly used for many procedures including joint
aspiration and injection [7]. The administration of
lidocaine can be painful, but buffering it with sodium
bicarbonate has been shown to make its injection signifi-
cantly less painful.
Another technique of local anesthesia for IASI is
Lidocaine iontophoresis. It is a safe, non-invasive way of
delivering topical lidocaine. Low-level electrical current
drives the lidocaine into the skin [11]. The side-effects
include erythema, tingling and itching at the application
site. Iontophoresis may not be tolerated by all children
due to the discomfort from the electrical current.Conscious sedation
The increased availability of short-acting sedatives along
with accurate, noninvasive monitoring and improved
sedation training programs have enabled effective and safe
management of sedation and analgesia outside the operating
room [12]. Several pharmacologic agents are being used in
the setting of sedation for IASI.
Nitrous oxide sedation
Nitrous oxide (N2O) is a volatile gas with analgesic, anxio-
lytic and sedative properties, when mixed with oxygen. It
is an effective sedative and analgesic for mildly to moder-
ately painful pediatric procedures. It has been reported
that N2O can be safely administered up to 70 % concen-
tration by nasal mask for pediatric procedural sedation,
particularly for short (<15 minutes) procedures [13].
Studies have shown that N2O provides safe and effective
analgesia for intra-articular injection in children [14, 15].
Common adverse effects reported include euphoria,
nausea and vomiting, clinically insignificant hypoxia,
dizziness, restlessness, and hallucinations. There have been
no serious adverse effects reported with its use [16, 17].
Another advantage of N2O, in addition to its safety, is
that the continuous flow method can be used in younger
patients. It is also significantly less costly than general
anesthesia.
Using N2O allows for a short hospital stay, avoids the
risks associated with intravenous sedation and general
anesthesia, and the procedure can usually be performed
quickly after the need is recognized [18].
Disadvantages of N2O include the need for a mask or
mouthpiece. Cleary et al. found that a mask was more
likely to induce a state of anxiety and nausea in the patient
[14]. Another disadvantage is the possibility of nasal
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haled gas; hence, inadequate sedation effect. Experienced
staff can overcome this problem.
N2O combined with distraction techniques
Relaxation before and a comfortable atmosphere during
sedation, make the procedure easier to perform. Cleary
et al. reported relaxation techniques, including using a
play specialist prior to the procedure, music and the use
of laser light [18]. It is possible that these techniques
explain their relative low visual analog scale for pain
(VAS score, scored from 0 the lowest to 10 the highest) as
compared to other similar studies (median VAS of 1, vs.
mean of 2.1) [14, 15]. It is also possible that response to
pain is culturally dependent and their lower scores
are partially explained by the relatively calm British
temperament.
The goal of distraction therapy is to shift the patient’s
focus from the pain-inducing source. These methods have
been shown to decrease pain levels and improve physio-
logic parameters, such as blood pressure and tachycardia.
Several studies showed that the presence of trained
medical clowns significantly reduces preoperative anxiety
in children [19–21].
In the past few years, distraction therapy has been
encouraged for children undergoing painful procedures.
Following the introduction of “Dream Doctors” (i.e. trained
medical clowns) in our hospital, we added a medical clown
as an integral part of the team performing IASI. We
reported that active participation of a medical clown during
IACS with nitrous oxide for JIA further decreases pain
and stress, and induces a pleasant patient experience [22].
Benzodiazepines
Benzodiazepines are commonly used for conscious
sedation. The drug can be administered by oral, rectal,
nasal, intramuscular and intravenous routes.
Midazolam is the most commonly used benzodiazepine
for procedural sedation and analgesia. Time to peak effect
for midazolam is brief with intravenous administration
(2–3 min) and duration is short (45–60 min). Paradoxical
reactions, characterized by inconsolable crying, combat-
iveness, disorientation, agitation and restlessness, have
been reported in 1–15 % of children receiving midazolam.
They have also been reported with intramuscular, intranasal,
and rectal administration of benzodiazepines [23].
This method of sedation requires insertion of an
intravenous cannula, which is often a distressing proced-
ure for the children. In addition, midazolam has no anal-
gesic property, so for painful procedures it is commonly
administered together with an opioid, a practice that may
decrease the safety profile of midazolam due to the
possibility of respiratory depression [24]. Due to the
above, this method should only be used when adequatefacilities for pediatric sedation and resuscitation are avail-
able. Midazolam can be used alone with local anesthesia
as well in the cooperative child. Despite its disadvantages,
it should be noted that when using standard precautions,
the safety profile for midazolam is excellent and its antero-
grade amnestic effect is well recognized.
Ketamine
Ketamine hydrochloride is a phencyclidine that binds to
NMDA receptors and promotes intense analgesia,
sedation and amnesia. It induces a trancelike state in
which the patient is unaware, but not necessarily asleep. It
can be administered by oral, intravenous and intramuscular
routes.
With intravenous administration, peak concentration is
achieved within 1 minute, allowing an immediate clinical
effect. This route of administration allows deep levels of
sedation to be achieved with good tolerance of extremely
painful procedures.
Ketamine administration results in sympathetic stimula-
tion and may increase heart rate and blood pressure, as
well as intracranial pressure. Additional side effects
include increased salivation, vomiting and rarely, apnea or
laryngospasm. Despite the above, its safety in sedation
among children has been largely reported [25].
Propofol
Propofol is an ultra-short-acting potent sedative, hypnotic
medication with no analgesic properties. Compared to
other commonly used agents, propofol has the fastest
onset of action and one of the shortest recovery times.
Clinical effect is usually achieved within 30 seconds of
administration. Adverse effects requiring routine interven-
tion by appropriately trained providers occur in approxi-
mately 2-5 % of children undergoing propofol sedation
and include respiratory obstruction, respiratory depres-
sion, apnea, and hypotension. Its main disadvantage as a
drug used in procedural sedation is its narrow therapeutic
index, i.e. its possibility of rapidly inducing anesthesia with
loss of airway reflexes, upper airway obstruction and
respiratory depression [26].
Fentanyl
Sedative-hypnotic agents, such as propofol and midazolam
do not have analgesic properties and need to be combined
with other analgesic agents to provide effective sedation
for painful procedures. Fentanyl is a synthetic opioid that
provides analgesia for procedures with moderate to severe
pain. Its rapid peak effect (within 5 minutes) and relatively
short duration of action render it preferable for procedural
sedation when compared to longer acting opioids, such as
morphine [23]. Although typically administered paren-
terally, fentanyl also can be effective when used intrana-
sally or via nebulizer.
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when fentanyl is combined with other sedatives (e.g.,
propofol, midazolam). Chest wall and glottic rigidity are
rare, but life-threatening adverse effects of fentanyl [27].
Because of the above, fentanyl should be given only by an
anesthesiologist or by a non-anesthesiologist physician who
has undergone a specialized sedation course and when
adequate facilities for pediatric resuscitation are available.
General anesthesia
Young children, or those requiring multiple joint injections,
will require general anesthesia. Some pediatric rheumatol-
ogy units routinely use general anesthesia for intra-articular
injection. With modern anesthesia techniques, the children
can often undergo this procedure in the anesthesia room
under a short, general anesthetic, and all can be treated as
day cases [18].
If the child is uncooperative in the pre-anesthetic phase,
a number of effective non-traumatic measures may be im-
plemented, such as distraction by a medical clown, parent
or other members of the operating room team. Failing the
above, oral midazolam syrup may be administered 30–45
minutes prior to induction of anesthesia [28].
The major advantage of general anesthesia is its rapid
onset and offset of action. An example may include the
inhalation by mask of 70 % N2O in oxygen for 2 minutes,
followed by the introduction of a potent, volatile anesthetic
agent like sevoflurane until consciousness is lost. This
technique combines both agents in a synergistically, with
the N20 providing the analgesic component and sevoflurane
providing the hypnotic component [29]. Anesthesia can be
maintained with this mixture, while the child breaths
spontaneously throughout the procedure. This is a good
opportunity for painless venipuncture and procurement of
necessary periodic blood tests. If there is no need for
venipuncture, a general anesthetic of 3–5 minutes duration
can be safely performed by a pediatric anesthesiologist
without an IV line.
An alternative method is to have potential venipuncture
sites pretreated with EMLA for a minimum of 45 minutes,
give 2 minutes of N2O inhalation, perform painless
venipuncture and then give intravenous propofol in suffi-
cient quantity for the remainder of the anesthetic period.
Again, the N20 is given for analgesia during the procedure
with the propofol providing the hypnosis. There is no need
for supplemental analgesia, as these injections rarely have
post-injection articular pain. From personal experience
(DH), children awakening from these short anesthetics may
be distressed by the unexpected appearance of an in situ IV
cannula and cannot be consoled until its removal. Using
both of the above methods, the child will typically emerge
from anesthesia to consciousness at the end of the proced-
ure and will be ready for home discharge in 90 minutes.
Side effects may include nausea and vomiting and deliriumupon emergence. Of interest, a small crossover study
comparing propofol and sevoflurane on emergence agita-
tion in repeat anesthesia for ocular examinations displayed
significantly more agitation after sevoflurane (38 %) versus
none in the propofol group [30]. For ultra-short general
anesthetics, these effects appear to be rare.
Conclusions
Intra-articular injection in JIA is a safe, rapidly effective
treatment for synovitis. The procedure can be facilitated
in an ambulatory care setting using local anesthesia with
or without moderate sedation, or under general anesthesia
in an operating room or office based environment.
As mentioned above, one of the disadvantages of IASI is
the pain associated with the procedure. In one survey look-
ing at the use of IASI for treatment of juvenile idiopathic
arthritis, 43 % of respondents regarded procedure-related
pain as a disadvantage of IASI therapy [31].
A number of individual differences affect children’s
reports of painful events, including age, anxiety, tem-
perament, pain response, and prior experience [32]. In 2
separate studies of medical procedures, children who
had more distressing previous experiences were found to
be more anxious and distressed than children who had
primarily positive or neutral experiences with procedures
[33, 34]. Since JIA is a chronic disease and many affected
children will experience numerous injections during the
course of their illness, much emphasis should be given
in making the procedure as painless, stress free and even
pleasant as possible.
In summary, few sedative methods are available to
pediatric rheumatologists for IASI. There is no accepted
standard of care regarding sedation, and each treating
physician should feel comfortable and safe using the
appropriate method. The decision should be taken after
consulting pediatric anesthesia colleagues and taking
into consideration the trained staff and the patient him-
self. Further studies are needed to determine the optimal
method of sedation to minimize pain and anxiety associ-
ated with IASI.
Back to the cases
Case 1
This patient is very young and therefore will probably not
cooperate with a painful procedure. It is very difficult for
this age group to hold still, thus jeopardizing the accuracy
of the injection. Therefore, in our opinion this patient
should undergo the IASI under general anesthesia or
moderate sedation. Since this girl will probably need
repeated injections in the future, it is important to make
the procedure as painless as possible for her in order to
reduce anxiety before subsequent procedures. A positive
family unit, child life specialist or medical clown may
facilitate these as positive experiences.
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In this case considering the patient’s age and experience
with a former IASI, the preferred mode of sedation in
our opinion would be N2O combined with a distraction
technique, such as a medical clown. This way the patient
will not have to face the stress of intravenous cannula
insertion and will avoid the risks of benzodiazepine
sedation. The presence of a medical clown will help
make the procedure as pleasant as possible for her.
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